CEFEXITAB

This brand name is authorized in Nigeria.

Active ingredients

The drug CEFEXITAB contains a combination of these active pharmaceutical ingredients (APIs):

1	Cefixime UNII 97I1C92E55 - CEFIXIME
	Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms.
	Read more about Cefixime
2	Clavulanic acid UNII Q42OMW3AT8 - CLAVULANATE POTASSIUM
	Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin.
	Read more about Clavulanic acid

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-0425	Tablet	CEFEXITAB 200 TABLET TAB 200 mg 1 X 10	154 CMS-PP-337115 CEFEXITAB 200 TABLET CEFIXIME USP (AS TRIHYDRATE) EQ. TO ANHYDROUS CEFIXIME 200 MG Cefixime trihydrate, Microcrystalline cellulose 102, Lactose monohydrate, Colloidal silicon dioxide (Aerosil), Talc, Croscarmellose sodium, Magnesium stearate, Color coat FC4S-I (Yellow), Isopropyl alcohol, Methylene chloride C4-0425 Drugs Imported Products 110 Prescription Only Medicine (POM) 6/7/2023 SJS LIFE SCIENCES LIMITED, 11, OLU AKERELE STREET, IKEJA, LAGOS 8114441430 sjslifesciencesltd@gmail.com GLOBELA LABORATORIES PRIVATE LIMITED, PLOT NO. 5536, ROAD NO. 55, G.I.D.C. ESTATE, SACHIN, SURAT – 394 230, INDIA, India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD08	Cefixime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-0425